Real world use of long-acting cabotegravir and rilpivirine in a HIV centre in Hong Kong

被引:0
作者
Chan, M. C. J. [1 ]
Chik, S. H. T. [1 ]
Lamb, S. S. [1 ]
Choi, Y. C. C. [1 ]
Lau, W. T. A. [1 ]
Leung, C. S. E. [1 ]
To, P. Y. L. [1 ]
Lau, P. L. D. [1 ]
Tsang, T. Y. O. [1 ]
机构
[1] Hosp Author Infect Dis Ctr, Hong Kong, Peoples R China
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
814
引用
收藏
页码:155 / 156
页数:2
相关论文
共 50 条
[41]   Impact of long-acting therapy on immune-activation and senescence in people with HIV(PWH) switching to long-acting injectable cabotegravir plus rilpivirine [J].
Guardiani, M. ;
Tortellini, E. ;
Carraro, A. ;
Zingaropoli, M. A. ;
Ansaldo, L. ;
Pace, P. ;
Dominelli, F. ;
Mengoni, F. ;
Vullo, V. ;
Mastroianni, C. M. ;
Marocco, R. ;
Del Borgo, C. ;
Lichtner, M. .
JAC-ANTIMICROBIAL RESISTANCE, 2025, 7
[42]   Real life data on clinical and laboratory outcomes of long acting cabotegravir and rilpivirine in people with HIV [J].
Mazzitelli, M. ;
Agostini, E. ;
Sasset, L. ;
Leoni, D. ;
Gardin, S. ;
Presa, N. ;
Putaggio, C. ;
Bragato, B. ;
Parisi, S. ;
Cattelan, A. .
HIV MEDICINE, 2023, 24 :152-153
[43]   Therapeutic review of cabotegravir/rilpivirine long-acting antiretroviral injectable and implementation considerations at an HIV specialty clinic [J].
Howe, Zach W. ;
Norman, Sarah ;
Lueken, Abbie F. ;
Huesgen, Emily ;
Farmer, Eric K. ;
Jarrell, Kaitlyn ;
Mathis, Joscelyn E. ;
Bonham, Kyle W. ;
Hahn, Julie .
PHARMACOTHERAPY, 2021, 41 (08) :686-699
[44]   Early Experience and Effectiveness of Long-Acting Injectable Cabotegravir and Rilpivirine in a South Side Chicago HIV Clinic [J].
Liegeon, Geoffroy ;
Kaperak, Christopher ;
Friedman, Eleanor E. ;
Djuricich, Paul ;
Dawdani, Alicia ;
Stafford, Kane ;
Plotkin, Sophie ;
Schmitt, Jessica ;
Hazra, Aniruddha ;
Christopoulos, Katerina A. ;
Schneider, John A. ;
Mcnulty, Moira C. .
OPEN FORUM INFECTIOUS DISEASES, 2025, 12 (03)
[45]   Patient-reported outcomes in switching to long-acting cabotegravir/rilpivirine: a real-life experience [J].
Carraro, Anna ;
Marocco, Raffaella ;
Mancarella, Giulia ;
Zuccala, Paola ;
Ansaldo, Lorenzo ;
De Maria, Sara ;
Corazza, Sara ;
Grimaldi, Alessandra ;
Gasperin, Andrea ;
Del Borgo, Cosmo ;
Lichtner, Miriam .
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 :116-116
[46]   Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis [J].
Cutrell, Amy G. ;
Schapiro, Jonathan M. ;
Perno, Carlo F. ;
Kuritzkes, Daniel R. ;
Quercia, Romina ;
Patel, Parul ;
Polli, Joseph W. ;
Dorey, David ;
Wang, Yongwei ;
Wu, Sterling ;
Van Eygen, Veerle ;
Crauwels, Herta ;
Ford, Susan L. ;
Baker, Mark ;
Talarico, Christine L. ;
St Clair, Marty ;
Jeffrey, Jerry ;
White, C. Thomas ;
Vanveggel, Simon ;
Vandermeulen, Kati ;
Margolis, David A. ;
Aboud, Michael ;
Spreen, William R. ;
van Lunzen, Jan .
AIDS, 2021, 35 (09) :1333-1342
[47]   Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential [J].
Fernandez, Cristina ;
van Halsema, Clare L. .
HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2019, 11 :179-192
[48]   Long-Acting Cabotegravir/Rilpivirine Concentrations in Combination With Intravenous Rifampin: A Case Report [J].
Sunagawa, Shawnalyn W. ;
Havens, Joshua P. ;
Podany, Anthony ;
Walker, Bryan ;
Scarsi, Kimberly K. ;
Bares, Sara H. .
OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (12)
[49]   Characterization of a case of virological failure after switch to long-acting cabotegravir and rilpivirine [J].
Mazzitelli, Maria ;
Avolio, Antonio ;
Carandina, Riccardo ;
Parisi, Saverio ;
Wensing, Annemarie ;
Cattelan, Annamaria .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (08) :2074-2076
[50]   Efficacy, Safety and Retention in Care Among Adolescents and Youth With HIV on Long-acting Injectable Cabotegravir/Rilpivirine Treatment: Real-world Observational Cohort Outcomes [J].
Williams, Tierra ;
Unternaher, Justin ;
Koay, Wei Li Adeline ;
Anderson, Lorato ;
Bright, Kimberly ;
Mareuil, Joanna ;
Rakhmanina, Natella .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2025, 44 (07) :650-656